Consolidated*
Revenue +34% YoY
Gross Profit Margin 59.3% vs 46.3% YoY
EBITDA +98% YoY
EBITDA Margin 31.8% vs 21.5% YoY
PBT +148% YoY
PAT +134% YoY
Segmental Revenue:-
Consumer 134.9 Cr (-3% YoY)
Healthcare 98.6 Cr (+163% YoY)
Industrial 23.2 Cr (+45% YoY)
→Volume of Polymers Processed (MT)
6,652 MT in Q2FY26 (+7.5% YoY)
→Machine utilization improved to 47.7% (up 560 bps YoY)
→ROCE 42.3% (vs 24.4% in Mar’25)
→ROE 32.7% (vs 18.5% in Mar’25)
Business Update:-
- Healthcare
→Installed 19 new machines during Q2FY26, expanding capacity for precision molding.
→Exhibited at CPHI Frankfurt, PDA Europe, and PODD Boston, holding 100+ meetings with potential clients.
→Launched “Shaily Axiom Max” – a fixed dose injection pen.
→Signed 4 new projects across GLP1 and other therapeutic categories.
-
Consumer
→New Business awarded for 5 new projects with 3 home furnishing customers -
Industrial
→New Business awarded for 1 new project with automotive customer
BUMPER RESULTS